1. Home
  2. YMAB vs NFBK Comparison

YMAB vs NFBK Comparison

Compare YMAB & NFBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YMAB
  • NFBK
  • Stock Information
  • Founded
  • YMAB 2015
  • NFBK 1887
  • Country
  • YMAB United States
  • NFBK United States
  • Employees
  • YMAB N/A
  • NFBK N/A
  • Industry
  • YMAB Biotechnology: Pharmaceutical Preparations
  • NFBK Major Banks
  • Sector
  • YMAB Health Care
  • NFBK Finance
  • Exchange
  • YMAB Nasdaq
  • NFBK Nasdaq
  • Market Cap
  • YMAB 386.7M
  • NFBK 447.8M
  • IPO Year
  • YMAB 2018
  • NFBK 2007
  • Fundamental
  • Price
  • YMAB $8.57
  • NFBK $11.86
  • Analyst Decision
  • YMAB Buy
  • NFBK Buy
  • Analyst Count
  • YMAB 10
  • NFBK 2
  • Target Price
  • YMAB $13.91
  • NFBK $13.00
  • AVG Volume (30 Days)
  • YMAB 2.2M
  • NFBK 157.8K
  • Earning Date
  • YMAB 08-08-2025
  • NFBK 10-22-2025
  • Dividend Yield
  • YMAB N/A
  • NFBK 4.39%
  • EPS Growth
  • YMAB N/A
  • NFBK 28.89
  • EPS
  • YMAB N/A
  • NFBK 0.86
  • Revenue
  • YMAB $85,385,000.00
  • NFBK $133,079,000.00
  • Revenue This Year
  • YMAB N/A
  • NFBK $8.04
  • Revenue Next Year
  • YMAB $13.97
  • NFBK $23.35
  • P/E Ratio
  • YMAB N/A
  • NFBK $13.75
  • Revenue Growth
  • YMAB N/A
  • NFBK 4.86
  • 52 Week Low
  • YMAB $3.55
  • NFBK $9.40
  • 52 Week High
  • YMAB $16.11
  • NFBK $14.39
  • Technical
  • Relative Strength Index (RSI)
  • YMAB 81.31
  • NFBK 61.15
  • Support Level
  • YMAB $8.50
  • NFBK $10.81
  • Resistance Level
  • YMAB $8.56
  • NFBK $11.99
  • Average True Range (ATR)
  • YMAB 0.02
  • NFBK 0.28
  • MACD
  • YMAB -0.12
  • NFBK 0.10
  • Stochastic Oscillator
  • YMAB 83.33
  • NFBK 88.98

About YMAB Y-mAbs Therapeutics Inc.

Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.

About NFBK Northfield Bancorp Inc. (Delaware)

Northfield Bancorp Inc is the holding company for Northfield Bank. Its subsidiary provides banking services to individuals and corporate customers in Richmond and Kings Counties in New York, and Hunterdon, Mercer, Union and Middlesex counties in New Jersey. The bank attracts deposits and offers credit and other banking services.

Share on Social Networks: